Services provided such as early and late stage product acquisitions, maximizing market share, and enhancing employee contributions to improve their products and services for their customers are key deliverables that Healthcare Economics will contribute to your firm to sustain a continuum of steady and consistent growth.
Product Candidate Acquisition: Early Stage
Contract Development Manufacturing Organizations (CDMO) and academia are focused on conceptualizing and developing early stage product candidates that will eventually satisfy unmet medical needs. Early stage product candidates are those products that have met and succeeded the proof of concept requirement and have been proven successfully in phase I studies.
At this stage commercial viability has yet to be proven due to the fact that many stages of development remain. The opportunity to out-license an early stage product candidate to commercial firms is highly attractive for early stage developers and established commercial firms.
Developers seek revenue and partners in order to fulfill their mission of product development and sustained inflow of capital while biotech and pharma firms seek to supplant existing therapies at the end of their product life cycle with new and highly desirable candidates to capture market share and meet unmet medical needs. HCE with its experienced team and established networks will be instrumental in executing in-licensing, out-licensing, joint ventures, co-marketing, co-promotional, and cross licensing arrangements for business partners.